Fragasso Group Inc. Laboratory Corp Of America Holdings Transaction History

Fragasso Group Inc.

$1.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	SELL	$192.5 - $216.35 $1.31 Million - $1.47 Million	-6,796 Reduced 33.1%	13,735 $2.8 Million
Q1 2024 Apr 10, 2024	SELL	$209.01 - $232.56 $74,825 - $83,256	-358 Reduced 1.71%	20,531 $4.49 Million
Q4 2023 Jan 08, 2024	BUY	$197.69 - $227.29 $199,073 - $228,881	1,007 Added 5.06%	20,889 $4.75 Million
Q3 2023 Dec 06, 2023	SELL	$201.05 - $221.7 $27,141 - $29,929	-135 Reduced 0.67%	19,882 $4 Million
Q2 2023 Jul 10, 2023	SELL	$211.93 - $241.33 $1.12 Million - $1.27 Million	-5,269 Reduced 20.84%	20,017 $4.83 Million
Q1 2023 Apr 13, 2023	BUY	$213.32 - $257.83 $215,026 - $259,892	1,008 Added 4.15%	25,286 $5.8 Million
Q4 2022 Jan 24, 2023	BUY	$203.72 - $248.97 $284,596 - $347,811	1,397 Added 6.11%	24,278 $0
Q4 2022 Jan 24, 2023	SELL	$203.72 - $248.97 $4.95 Million - $6.04 Million	-24,278 Closed	0 $0
Q3 2022 Oct 13, 2022	BUY	$204.81 - $262.19 $189,039 - $242,001	923 Added 4.2%	22,881 $4.69 Million
Q2 2022 Aug 30, 2022	BUY	$213.86 - $277.87 $275,023 - $357,340	1,286 Added 6.22%	21,958 $5.15 Million
Q1 2022 Apr 06, 2022	BUY	$259.82 - $298.18 $297,234 - $341,117	1,144 Added 5.86%	20,672 $5.45 Million
Q4 2021 Jan 19, 2022	BUY	$271.6 - $314.21 $304,735 - $352,543	1,122 Added 6.1%	19,528 $6.14 Million
Q3 2021 Oct 08, 2021	BUY	$274.82 - $308.34 $360,289 - $404,233	1,311 Added 7.67%	18,406 $5.18 Million
Q2 2021 Jul 19, 2021	BUY	$251.87 - $278.14 $471,500 - $520,678	1,872 Added 12.3%	17,095 $4.72 Million
Q1 2021 May 27, 2021	BUY	$204.88 - $255.03 $3.12 Million - $3.88 Million	15,223 New	15,223 $3.88 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Account